| Overview |
| bs-25219R-Cy5 |
| NALP4 Polyclonal Antibody, Cy5 Conjugated |
| WB |
| Human |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human NALP4 |
| Polyclonal |
| IgG |
| 1mg/ml |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 147945 |
| Q96MN2 |
| Cytoplasm, Secreted, Extracellular matrix |
| Nucleotide binding oligomerization domain, leucine rich repeat and pyrin domain containing 4; Cancer/testis antigen 58; CLR19.5; CT58; NACHT, leucine rich repeat and PYD containing 4; NACHT, LRR and PYD containing protein 4; NACHT, LRR and PYD domains-containing protein 4; NALP4_HUMAN; NLR family, pyrin domain containing 4; NLRP4; NALP4G; PAAD and NACHT containing protein 2; PAAD and NACHT-containing protein 2; PAN2; PYPAF4; PYRIN and NACHT-containing protein 2; PYRIN containing APAF1 like protein 4; PYRIN-containing APAF1-like protein 4; Ribonuclease inhibitor 2; RNH2. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz